The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
We strive to contribute to progress through the development of innovative technologies and sustainable solutions, according to the latest GMP (Good Manufacturing Practice) regulations. We continue to implement large investments in Research & Development in order to be at the forefront and maintain a technological advantage in the sector. In the field of Pharma for aseptic processing of pharmaceutical products Comecer develops standard and tailored solutions for the production of isolators for the treatment of toxic and non-toxic substances to be used in pharmaceutical production companies, in university research centres, in hospitals, and in small as well as in large industrial groups worldwide. We gained experience in manual and semi-automatic sterile processing of cytotoxic antiblastic drugs in hospital pharmacies. All systems are tested and undergo a comprehensive series of validation checks according to the applicable standards and norms. The “Safety First” Code of Ethics applies inside Comecer, which translates into quality of materials and processes and allows Comecer to qualify its products in accordance with the highest standards in the sector.